ADCYAP1 and migraine disorder: A key role in the development of migraine attacks is played by the activation of the trigeminovascular nociceptive pathways, resulting in the release of neurochemical mediators such as calcitonin gene-related protein (CGRP) and pituitary adenylate cyclase activating polypeptide (PACAP), which can trigger migraine pain [5].